See more : Viking Energy Group, Inc. (VKIN) Income Statement Analysis – Financial Results
Complete financial analysis of MoneyGram International, Inc. (MGI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MoneyGram International, Inc., a leading company in the Financial – Credit Services industry within the Financial Services sector.
You may be interested
- Raymond Lifestyle Limited (RAYMONDLSL.BO) Income Statement Analysis – Financial Results
- Guardforce AI Co., Limited (GFAI) Income Statement Analysis – Financial Results
- Box, Inc. (0HP1.L) Income Statement Analysis – Financial Results
- Hangzhou Pinming Software Co., Ltd (688109.SS) Income Statement Analysis – Financial Results
- Pushpay Holdings Limited (PHPYF) Income Statement Analysis – Financial Results
MoneyGram International, Inc. (MGI)
Industry: Financial - Credit Services
Sector: Financial Services
Website: https://corporate.moneygram.com
About MoneyGram International, Inc.
MoneyGram International, Inc., together with its subsidiaries, provides cross-border peer-to-peer payments and money transfer services in the United States and internationally. The company operates through two segments, Global Funds Transfer and Financial Paper Products. The Global Funds Transfer segment offers money transfer services and bill payment services through third-party agents, including retail chains, independent retailers, post offices, banks, and other financial institutions; and digital solutions, such as moneygram.com, account deposit, and kiosk-based services, as well as mobile app solutions. The Financial Paper Products segment provides money orders to consumers through its agents and financial institutions under the MoneyGram brand and on a private label or co-branded basis with various agents and financial institutions; and official check outsourcing services for banks and credit unions. MoneyGram International, Inc. was incorporated in 2003 and is based in Dallas, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.31B | 1.28B | 1.22B | 1.29B | 1.45B | 1.60B | 1.63B | 1.43B | 1.45B | 1.47B | 1.34B | 1.25B | 1.17B | 1.17B | 927.12M | 157.54M | 1.16B | 971.24M | 826.53M | 737.22M | 1.28B | 305.97M |
| Cost of Revenue | 918.20M | 911.90M | 876.80M | 890.60M | 992.00M | 1.05B | 1.09B | 965.30M | 941.40M | 943.10M | 841.10M | 548.00M | 501.50M | 498.47M | 604.61M | 663.91M | 563.66M | 470.47M | 151.60M | 377.33M | 684.10M | 0.00 |
| Gross Profit | 391.90M | 371.70M | 340.40M | 394.50M | 455.60M | 552.20M | 539.70M | 469.40M | 513.50M | 531.30M | 500.10M | 699.77M | 665.16M | 673.44M | 322.51M | -506.37M | 595.90M | 500.76M | 674.94M | 359.89M | 599.50M | 305.97M |
| Gross Profit Ratio | 29.91% | 28.96% | 27.97% | 30.70% | 31.47% | 34.47% | 33.10% | 32.72% | 35.29% | 36.03% | 37.29% | 56.08% | 57.01% | 57.47% | 34.79% | -321.43% | 51.39% | 51.56% | 81.66% | 48.82% | 46.70% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 59.80M | 241.00M | 173.00M | 268.70M | 360.80M | 468.40M | 371.40M | 387.10M | 386.60M | 302.70M | 403.40M | 511.20M | 458.69M | 510.51M | 490.48M | 423.86M | 372.22M | 314.32M | 0.00 | 234.57M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 59.80M | 241.00M | 173.00M | 268.70M | 360.80M | 468.40M | 371.40M | 387.10M | 386.60M | 302.70M | 403.40M | 511.20M | 458.69M | 510.51M | 490.48M | 423.86M | 372.22M | 314.32M | 126.64M | 234.57M | 0.00 | 0.00 |
| Other Expenses | 238.90M | 57.00M | 64.40M | 73.80M | 24.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 525.80M | 0.00 |
| Operating Expenses | 298.70M | 298.00M | 237.40M | 342.50M | 437.10M | 543.50M | 451.30M | 453.20M | 442.10M | 353.40M | 447.70M | 557.25M | 506.76M | 567.60M | 547.15M | 475.84M | 411.20M | 346.78M | 609.81M | 261.86M | 525.80M | 0.00 |
| Cost & Expenses | 1.22B | 1.21B | 1.11B | 1.23B | 1.43B | 1.59B | 1.54B | 1.42B | 1.38B | 1.30B | 1.29B | 1.11B | 1.01B | 1.07B | 1.15B | 1.14B | 974.86M | 817.25M | 761.40M | 639.20M | 1.21B | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 395.49M | 367.99M | 0.00 | 323.10M | 0.00 | 0.00 |
| Interest Expense | 49.40M | 69.50M | 92.40M | 77.00M | 53.60M | 45.30M | 45.00M | 45.30M | 44.20M | 47.30M | 70.90M | 86.17M | 102.13M | 107.91M | 95.02M | 11.06M | 7.93M | 7.61M | 5.57M | 9.86M | 69.50M | 0.00 |
| Depreciation & Amortization | 47.70M | 53.30M | 59.90M | 73.80M | 76.30M | 75.10M | 79.90M | 66.10M | 55.50M | 50.70M | 44.30M | 46.05M | 48.07M | 57.09M | 56.67M | 51.98M | 38.98M | 32.47M | 29.57M | 27.30M | 57.00M | 27.15M |
| EBITDA | 140.90M | 127.00M | 162.90M | 86.50M | 119.00M | 83.80M | 168.30M | 82.30M | 126.90M | 228.60M | 96.30M | 188.57M | 206.47M | 162.93M | -167.97M | -930.23M | 223.68M | 186.45M | 145.44M | 125.32M | 82.90M | 333.12M |
| EBITDA Ratio | 10.75% | 9.89% | 13.38% | 6.73% | 8.22% | 5.23% | 10.32% | 5.74% | 8.72% | 15.50% | 7.18% | 15.11% | 17.70% | 13.90% | -18.12% | -590.49% | 19.29% | 19.20% | 62.77% | 17.00% | 6.46% | 108.87% |
| Operating Income | 93.20M | 73.70M | 103.00M | 12.70M | 18.50M | 8.70M | 88.40M | 16.20M | 71.40M | 177.90M | 52.40M | 142.52M | 158.40M | 85.59M | -337.19M | -993.27M | 184.70M | 153.98M | 65.13M | 98.03M | 73.70M | 305.97M |
| Operating Income Ratio | 7.11% | 5.74% | 8.46% | 0.99% | 1.28% | 0.54% | 5.42% | 1.13% | 4.91% | 12.07% | 3.91% | 11.42% | 13.58% | 7.30% | -36.37% | -630.50% | 15.93% | 15.85% | 7.88% | 13.30% | 5.74% | 100.00% |
| Total Other Income/Expenses | -53.40M | -117.30M | -96.90M | -77.00M | -29.40M | -45.30M | -45.30M | -45.30M | 1.20M | -92.60M | -61.30M | -102.75M | -100.02M | -87.66M | 0.00 | 0.00 | -7.93M | -7.61M | 23.89M | -9.86M | -117.30M | -246.02M |
| Income Before Tax | 39.80M | -43.60M | 6.10M | -64.30M | -10.90M | -36.60M | 43.10M | -29.10M | 72.60M | 85.30M | -8.90M | 39.77M | 58.38M | -2.07M | -337.19M | -993.27M | 176.77M | 146.38M | 89.02M | 88.17M | -43.60M | 59.95M |
| Income Before Tax Ratio | 3.04% | -3.40% | 0.50% | -5.00% | -0.75% | -2.28% | 2.64% | -2.03% | 4.99% | 5.79% | -0.66% | 3.19% | 5.00% | -0.18% | -36.37% | -630.50% | 15.24% | 15.07% | 10.77% | 11.96% | -3.40% | 19.59% |
| Income Tax Expense | 5.60M | -5.70M | 14.00M | -4.00M | 13.10M | -6.80M | 26.80M | 47.80M | 500.00K | 32.90M | 40.40M | -19.64M | 14.58M | -20.42M | -75.81M | 78.48M | 52.72M | 34.17M | 23.89M | 12.49M | -5.70M | -15.10M |
| Net Income | 34.20M | -37.90M | -7.90M | -60.30M | -24.00M | -29.80M | 16.30M | -76.90M | 72.10M | 52.40M | -49.30M | 59.41M | 43.80M | 18.34M | -261.39M | -1.07B | 124.05M | 112.95M | 86.41M | 113.90M | -37.90M | 75.05M |
| Net Income Ratio | 2.61% | -2.95% | -0.65% | -4.69% | -1.66% | -1.86% | 1.00% | -5.36% | 4.96% | 3.55% | -3.68% | 4.76% | 3.75% | 1.57% | -28.19% | -680.47% | 10.70% | 11.63% | 10.45% | 15.45% | -2.95% | 24.53% |
| EPS | 0.35 | -0.42 | -0.10 | -0.85 | -0.37 | -0.47 | 0.26 | -1.24 | 1.10 | 0.73 | -0.69 | -9.03 | -8.80 | -9.92 | -25.36 | -103.55 | 11.76 | 10.64 | 7.92 | 10.48 | -0.42 | 6.76K |
| EPS Diluted | 0.34 | -0.42 | -0.10 | -0.85 | -0.37 | -0.47 | 0.25 | -1.24 | 1.10 | 0.73 | -0.69 | -9.03 | -8.80 | -9.92 | -25.36 | -103.55 | 11.60 | 10.48 | 7.92 | 10.48 | -0.42 | 6.60K |
| Weighted Avg Shares Out | 96.40M | 89.70M | 77.80M | 71.10M | 64.30M | 62.90M | 62.30M | 62.10M | 65.30M | 71.60M | 71.50M | 48.60M | 10.40M | 10.31M | 10.31M | 10.35M | 10.54M | 10.58M | 10.86M | 10.78M | 89.70M | 11.10K |
| Weighted Avg Shares Out (Dil) | 100.10M | 89.70M | 77.80M | 71.10M | 64.30M | 62.90M | 65.90M | 62.10M | 65.50M | 71.90M | 71.50M | 48.60M | 10.40M | 10.31M | 10.31M | 10.35M | 10.73M | 10.75M | 10.92M | 10.83M | 89.70M | 11.37K |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MoneyGram International, Inc. - MGI
NEW YORK , Jan. 12, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MoneyGram International, Inc. ("MoneyGram" or the "Company") (NASDAQ: MGI). Such investors are advised to contact Robert S.
Global Single Cell Genomics Market Report 2023: Single Cell Genomics Identifying New Forms of Life, Driving Enormous New Research Area with Wide Health Care Applications - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Single Cell Genomics Market Forecasts by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates" report has been added to ResearchAndMarkets.com's offering. Single Cell Genomics is emerging as a mainstay...
MoneyGram Teams With CellPay to Expand Bill Payment Offering
MoneyGram has partnered with CellPay to expand its payment option to over 30,000 billers. “This strategic partnership further accelerates both companies' growth in a highly competitive bill payment arena,” the companies said in a news release Tuesday (Dec. 27).
Is This Coin on Track for 10X Returns in 2023?
2023 might be the year that Stellar finally breaks through the $1 mark.
MoneyGram Nears Completion of Merger Transaction with Madison Dearborn Partners
MoneyGram and MDP have received all but one regulatory approval and expect to close the transaction in early Q1 2023 DALLAS , Dec. 21, 2022 /PRNewswire/ -- MoneyGram International, Inc. (NASDAQ: MGI) (the "Company"), a global leader in the evolution of...
MoneyGram (MGI) Unveils Digital Money Transfers in Brazil
MoneyGram (MGI) introduces MGO in Brazil, by virtue of which the country's consumers can engage in hassle-free global digital money transfers.
Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA 2022: Minimized Risk of Human Error and Improved Quality Drives Adoption - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Distribution by Type of Monitoring Method, Bioprocessing Method, Working Volume, Scalability, Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering....
MoneyGram Launches MoneyGram Online ("MGO") Website in Brazil
Consumers can now use the Company's leading website to send funds from Brazil in near real-time to family and friends around the world MoneyGram is continuing to execute its strategy to accelerate the growth and geographic expansion of MoneyGram Online...
Worldwide NGS Market Forecasted to Grow at 15% p.a., to Reach ~$9.3B in 2025 – Market Report by DeciBio Consulting
LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC’s latest market report, “Next Generation Sequencing (NGS) Market Size, Growth and Trends (2019-2025),” predicts that the Next generation Sequencing market will grow to ~$9.3 billion (USD) in 2025 driven primarily by clinical adoption in oncology...
Why Is MoneyGram (MGI) Up 3.9% Since Last Earnings Report?
MoneyGram (MGI) reported earnings 30 days ago. What's next for the stock?
Source: https://incomestatements.info
Category: Stock Reports